161 related articles for article (PubMed ID: 11259832)
1. Role of dosage regimen in controlling indirect pharmacodynamic responses.
Gobburu JV; Jusko WJ
Adv Drug Deliv Rev; 2001 Mar; 46(1-3):45-57. PubMed ID: 11259832
[TBL] [Abstract][Full Text] [Related]
2. Role of dosage regimen in controlling indirect pharmacodynamic responses.
Jusko WJ; Gobburu JV
Adv Drug Deliv Rev; 1998 Sep; 33(3):221-233. PubMed ID: 10837662
[TBL] [Abstract][Full Text] [Related]
3. Role of baseline parameters in determining indirect pharmacodynamic responses.
Sun YN; Jusko WJ
J Pharm Sci; 1999 Oct; 88(10):987-90. PubMed ID: 10514344
[TBL] [Abstract][Full Text] [Related]
4. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
Chen ML
Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
[TBL] [Abstract][Full Text] [Related]
5. Assessment of drug interactions relevant to pharmacodynamic indirect response models.
Earp J; Krzyzanski W; Chakraborty A; Zamacona MK; Jusko WJ
J Pharmacokinet Pharmacodyn; 2004 Oct; 31(5):345-80. PubMed ID: 15669772
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic-pharmacodynamic relationship.
Baggot JD
Ann Rech Vet; 1990; 21 Suppl 1():29S-40S. PubMed ID: 2080844
[TBL] [Abstract][Full Text] [Related]
7. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
[TBL] [Abstract][Full Text] [Related]
8. Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics.
Gabrielsson J; Andersson K; Tobin G; Ingvast-Larsson C; Jirstrand M
Comput Methods Programs Biomed; 2014 Mar; 113(3):815-29. PubMed ID: 24461798
[TBL] [Abstract][Full Text] [Related]
9. Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.
Boissel JP; Nony P
Clin Pharmacokinet; 2002; 41(1):1-6. PubMed ID: 11825093
[TBL] [Abstract][Full Text] [Related]
10. Integrated functions for four basic models of indirect pharmacodynamic response.
Krzyzanski W; Jusko WJ
J Pharm Sci; 1998 Jan; 87(1):67-72. PubMed ID: 9452970
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of drug action in disease states. XXI. Relationship between drug infusion rate and dose required to produce a pharmacologic effect.
Klockowski PM; Levy G
J Pharm Sci; 1987 Jul; 76(7):516-20. PubMed ID: 3668811
[TBL] [Abstract][Full Text] [Related]
12. Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.
Krzyzanski W; Dmochowski J; Matsushima N; Jusko WJ
J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):635-55. PubMed ID: 16941234
[TBL] [Abstract][Full Text] [Related]
13. Feedback control indirect response models.
Zhang Y; D'Argenio DZ
J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):343-58. PubMed ID: 27394724
[TBL] [Abstract][Full Text] [Related]
14. Assessment of basic indirect pharmacodynamic response models with physiological limits.
Yao Z; Krzyzanski W; Jusko WJ
J Pharmacokinet Pharmacodyn; 2006 Apr; 33(2):167-93. PubMed ID: 16547797
[TBL] [Abstract][Full Text] [Related]
15. Interactive simulator for pharmacokinetics of repetitive drug dosing.
Iben GA; Anderson JH
Comput Programs Biomed; 1975 Mar; 4(3):113-20. PubMed ID: 1139911
[TBL] [Abstract][Full Text] [Related]
16. D-optimal designs for parameter estimation for indirect pharmacodynamic response models.
Khinkis LA; Krzyzanski W; Jusko WJ; Greco WR
J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):523-39. PubMed ID: 19904585
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic model for educational simulations.
van Meurs WL; Nikkelen E; Good ML
IEEE Trans Biomed Eng; 1998 May; 45(5):582-90. PubMed ID: 9581056
[TBL] [Abstract][Full Text] [Related]
18. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
[TBL] [Abstract][Full Text] [Related]
19. The integration of pharmacokinetics and pharmacodynamics: understanding dose-response.
Abdel-Rahman SM; Kauffman RE
Annu Rev Pharmacol Toxicol; 2004; 44():111-36. PubMed ID: 14744241
[TBL] [Abstract][Full Text] [Related]
20. Characterization of drug efficacy regions based on dosage and frequency schedules.
Li XL; Qian L; Bittner ML; Dougherty ER
IEEE Trans Biomed Eng; 2011 Mar; 58(3):488-98. PubMed ID: 21095860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
